Send the following on WhatsApp
Continue to ChatCanagliflozin lowers the risk of death from heart-related disease in high-risk type 2 diabetes patients https://www.ehealthwrites.com/canagliflozin-lowers-the-risk-of-death-from-heart-related-disease-in-high-risk-type-2-diabetes-patients/